Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial

Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial

Background. Dry eye disease (DED) is one of the most common complications following refractive surgery. Purpose. Evaluate the efficacy of an osmoprotective eye drop (Optive®) for the management of induced DED in refractive surgery patients. Design. Double-masked randomised controlled trial. Methods....

Full description

Saved in:
Bibliographic Details
Main Authors: R. M. Hazarbassanov, N. G. T. Queiroz-Hazarbassanov, J. N. Barros, J. A. P. Gomes
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2018/4324590
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items